<HTML>
<HEAD>
<TITLE>PSYCHIATRIC SOLUTIONS, INC.</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 1, 2005
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 0pt">REGISTRATION NO. 333-<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
</DIV>


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON, DC 20549</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>Form&nbsp;S-8</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REGISTRATION STATEMENT UNDER THE<BR>
SECURITIES ACT OF 1933</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>PSYCHIATRIC SOLUTIONS, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact Name of Registrant as Specified in its Charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>23-2491707</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or Other Jurisdiction of<BR>
Incorporation or Organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer<BR>
Identification No.)</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>840 Crescent Centre Drive, Suite&nbsp;460<BR>
Franklin, Tennessee</B><BR>
(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>37067</B><BR>
(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan</B></DIV>

<DIV align="center" style="font-size: 10pt">(Full title of the plan)</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Christopher L. Howard, Esq.<BR>
Executive Vice President, General Counsel and Secretary<BR>
Psychiatric Solutions, Inc.<BR>
840 Crescent Centre Drive, Suite&nbsp;460<BR>
Franklin, Tennessee 37067<BR>
(Name and Address of Agent for Service)</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt">(615)&nbsp;312-5700<BR>
(Telephone number, including area code, of agent for service)
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Copies of all communications to:<BR>
James H. Nixon III, Esq.<BR>
Waller Lansden Dortch &#038; Davis, PLLC<BR>
511 Union Street, Suite&nbsp;2700<BR>
Nashville, Tennessee 37219-1760<BR>
(615)&nbsp;244-6380</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>CALCULATION OF REGISTRATION FEE</B></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="34%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="18%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="16%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>

    <TD width="1%">&nbsp;</TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="15" style="border-bottom: 3px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Proposed</B></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Proposed</B></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Amount Of</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="center"><B>Title Of Each Class Of Securities To Be</B></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Amount To Be</B></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Maximum Offering Price</B></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Maximum Aggregate</B></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Registration</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="center"><B>Registered</B></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Registered (1)</B></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Per Unit</B></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Offering Price</B></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Fee (5)</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
                    <TD style="border-top: 1px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock of
Psychiatric
Solutions, Inc.,
par value $0.01 per
share</DIV></TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">1,650,151 (2)</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">$47.00 (4)</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">$77,557,097</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">$9,129</TD>
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock of
Psychiatric
Solutions, Inc.,
par value $0.01 per
share</DIV></TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">349,849 (3)</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">$44.92</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">$15,715,218</TD>
    <TD style="border-right: 1PX solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">$1,850</TD>
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000"><DIV style="margin-left:45px; text-indent:-15px">Total</DIV></TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">2,000,000</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">&#151;</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">$93,272,315</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 1px solid #000000">$10,979</TD>
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="15" style="border-top: 3px solid #000000">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<DIV style="margin-top: 3pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>


<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Pursuant to Rule 416 under the Securities Act of 1933, as
amended, this registration statement shall also cover additional
shares of common stock, par value $.01 per share (&#147;Common
Stock&#148;), of Psychiatric Solutions, Inc. (&#147;Psychiatric
Solutions&#148;) which become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction.</TD>
</TR>
<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>
<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents shares of Common Stock of
Psychiatric Solutions reserved for issuance pursuant to future
grants of stock options or restricted stock under the Amended and Restated Psychiatric Solutions, Inc. Equity
Incentive Plan, as amended (the &#147;Equity Incentive Plan&#148;).</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents shares reserved for issuance under the Equity Incentive Plan at a weighted-average
exercise price of $44.92 per share.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(4)</TD>
    <TD>&nbsp;</TD>
    <TD>Estimated pursuant to Rule 457(c) solely for purposes of calculating the amount of the
registration fee, based upon the average of the high and low prices of Common Stock of
Psychiatric Solutions, as reported on the Nasdaq National Market on August 26, 2005.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(5)</TD>
    <TD>&nbsp;</TD>
    <TD>The Equity Incentive Plan authorizes the issuance of a maximum of 4,933,333 shares of Common
Stock, of which 478,566 shares have been registered pursuant to a previously filed
registration statement on Form&nbsp;S-8 (No.&nbsp;333-38419), 333,333 shares have been registered on a
previously filed registration statement on Form&nbsp;S-8 (No.&nbsp;333-94983), 1,623,056 shares have
been registered pursuant to a previously filed registration statement on Form&nbsp;S-8 (No.
333-118529) and 166,666 shares have been registered on a previously filed registration
statement on Form&nbsp;S-8 (No.&nbsp;33-72664). In connection with the amendment and restatement of the
Equity Incentive Plan on May&nbsp;6, 2003, the Psychiatric Solutions, Inc. 1997 Incentive and
Non-Qualified Stock Option Plan for Key Personnel (the &#147;Psychiatric Plan&#148;) was merged into the
Equity Incentive Plan. The Psychiatric Plan authorized the issuance of a maximum of 331,712
shares of Common Stock, all of which shares have been registered pursuant to a previously
filed registration statement on Form&nbsp;S-8 (No.&nbsp;333-100635). An additional 2,000,000 shares of
Common Stock are being registered herewith and, in accordance with General Instruction E of
Form S-8, the fee is being paid only with respect to these shares. All share numbers,
purchase prices per share and exercise prices set forth in this registration statement have
been adjusted to reflect the exchange ratio in the merger between Psychiatric Solutions and
PMR Corporation on August&nbsp;5, 2002 and to reflect a 1-for-3 reverse stock split effected on
August&nbsp;5, 2002.</TD>
</TR>

</TABLE>
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">








<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Reoffer Prospectus</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>2,000,000 Shares</B>
</DIV>


<DIV align="center" style="font-size: 18pt; margin-top: 6pt"><B>Psychiatric Solutions, Inc.</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 6pt"><B>Common Stock</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus has been prepared for use by certain affiliates and employees (the &#147;Selling
Stockholders&#148;) of Psychiatric Solutions, Inc. (&#147;Psychiatric Solutions&#148;) who may offer and sell up
to an aggregate of 2,000,000 shares of common stock, par value $.01 per share (&#147;Common Stock&#148;),
that the Selling Stockholders acquire pursuant to the Amended and Restated Psychiatric Solutions,
Inc. Equity Incentive Plan, as amended (the &#147;Incentive Plan&#148;), or upon the exercise, subsequent to
the date of this reoffer prospectus, of stock options granted pursuant to the Incentive Plan.
</DIV>

<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus may only be used in conjunction with a supplement, if required under the
Securities Act of 1933, as amended (the &#147;Securities Act&#148;), that contains the names of the Selling
Stockholders and the amount of shares of Common Stock to be reoffered by them except with respect
to sales by non-affiliates of less than the lesser of 1,000 shares or one percent of the shares
issuable under the Incentive Plan.
</DIV>

<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will not receive any of the proceeds from the sale of the shares by the Selling
Stockholders. We will bear all expenses (other than underwriting discounts and selling
commissions, fees and expenses of counsel and other advisors to the Selling Stockholders, transfer
taxes and related charges) in connection with the registration of the shares being offered by the
Selling Stockholders.
</DIV>

<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Common Stock is listed on the Nasdaq National Market under the symbol &#147;PSYS.&#148; We are
incorporated under the laws of the State of Delaware. Our principal executive offices are located
at 840 Crescent Centre Drive, Suite&nbsp;460, Franklin, Tennessee 37067 and our telephone number is
(615)&nbsp;312-5700.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Investing in our Common Stock involves certain risks. Please carefully consider the &#147;Risk
Factors&#148; in our Annual Report on </B><B>Form 10-K</B><B> filed on March&nbsp;15, 2005, and incorporated by reference
into this prospectus.</B>
</DIV>

<DIV align="left" style="font-size: 9pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Neither the Securities and Exchange Commission (the &#147;SEC&#148;) nor any state securities commission
has approved or disapproved of these securities or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal offense.</B>
</DIV>

<DIV align="center" style="font-size: 9pt; margin-top: 18pt">The date of this prospectus is September&nbsp;1, 2005.
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<!-- TOC -->
</DIV>
<DIV align="left">
<A name="tocpage"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Heading</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#101">Use of Proceeds</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#102">Selling Stockholders</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#103">Plan of Distribution</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#104">Available Information</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#105">Incorporation of Certain Information By Reference</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#106">Legal Matters</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#107">Experts</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g97163exv5w1.txt">EX-5.1  OPINION OF WALLER LANSDEN DORTCH & DAVIS, PLLC</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g97163exv23w1.txt">EX-23.1  CONSENT OF ERNST & YOUNG LLP</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g97163exv23w2.txt">EX-23.2  CONSENT OF ERNST & YOUNG LLP</A></FONT></TD></TR>
</TABLE>
</DIV>

<DIV align="left">
<!-- /TOC -->
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<A name="101"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>USE OF PROCEEDS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will not receive any proceeds from the sale of shares of Common Stock by the Selling
Stockholders.
</DIV>
<DIV align="left">
<A name="102"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SELLING STOCKHOLDERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares of Common Stock issued pursuant to the Incentive Plan or upon the exercise,
subsequent to the date of this reoffer prospectus, of stock options granted pursuant to the
Incentive Plan have been registered under the Securities Act by a registration statement on Form
S-8. This prospectus is to be used in connection with any resales of Common Stock acquired
pursuant to the Incentive Plan after the date of the registration statement on Form S-8 by persons
who may be considered our &#147;affiliates&#148; within the meaning of the Securities Act and other persons
who, although not affiliates, may hold restricted securities previously issued through an employee
benefit plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At the date of this prospectus, we do not know the names of persons who intend to resell
shares of Common Stock acquired pursuant to the Incentive Plan. The Selling Stockholders will be
either employees, consultants or advisors of Psychiatric Solutions or its subsidiaries who have
been or may be granted options to purchase Common Stock or restricted shares of Common Stock under
the Incentive Plan. We will supplement this prospectus with the names of the Selling Stockholders
and the amount of shares of Common Stock to be reoffered by them as that information becomes known
and is required by the Securities Act.
</DIV>
<DIV align="left">
<A name="103"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PLAN OF DISTRIBUTION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares may be offered by the Selling Stockholders from time to time in transactions
through the Nasdaq National Market, in negotiated transactions, through the writing of options on
the shares or a combination of these methods of sale, at prices related to prevailing market prices
or at negotiated prices. The Selling Stockholders may effect these transactions by selling the
shares to or through broker-dealers and these broker-dealers may receive compensation in the form
of discounts, concessions or commissions from the Selling Stockholders and/or the purchaser of the
shares for which such broker-dealers may act as agent or to whom they sell as principal, or both.
This compensation as to a particular broker-dealer may be in excess of customary commissions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no assurance that any of the Selling Stockholders will sell any or all of the shares
of Common Stock offered under this prospectus.
</DIV>
<DIV align="left">
<A name="104"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AVAILABLE INFORMATION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are subject to the informational requirements of the Securities Exchange Act of 1934, as
amended (the &#147;Exchange Act&#148;), and, in accordance therewith, we file reports, proxy statements and
other information with the SEC under the Exchange Act. You may read and copy this information on
our website at www.psysolutions.com and at the following locations of the SEC:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="32%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Public Reference Room
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">New York Regional Office
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chicago Regional Office</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">450 Fifth Street, N.W.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Woolworth Center
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Citicorp Center, Suite&nbsp;1400</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Room&nbsp;1024
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">233 Broadway
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">500 West Madison Street</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Washington, D.C. 20549
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">New York, NY 10279
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chicago, IL 60661-2511</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may also obtain copies of this information by mail from the Public Reference Section of
the SEC, 450 Fifth Street, N.W., Room&nbsp;1024, Washington, D.C. 20549, at prescribed rates. You may
obtain information on the operation of the Public Reference Room by calling the SEC at
1-800-SEC-0330. The SEC also maintains an Internet world wide web site that contains reports, proxy
</DIV>

<P align="center" style="font-size: 10pt">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">statements and other information about issuers, like us, that file electronically with the
SEC. The address of that site is http://www.sec.gov. You may also inspect reports, proxy statements
and other information about us at the offices of the Nasdaq Stock Market, 9600 Blackwell Road,
Rockville, Maryland 20850.
</DIV>
<DIV align="left">
<A name="105"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The SEC allows us to &#147;incorporate by reference&#148; information into this prospectus from
documents that we have previously filed with the SEC. This means that we can disclose important
information to you by referring you to another document filed separately with the SEC. These
documents contain important information about us and our financial condition. The information
incorporated by reference is considered to be a part of this prospectus, except for any information
that is superseded by other information that is set forth directly in this document.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus incorporates by reference the following documents with respect to us (file
number: 0-20488):
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our annual report on Form 10-K for the year ended December&nbsp;31, 2004;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our quarterly reports on Form 10-Q for the quarters ended March&nbsp;31, 2005 and
June&nbsp;30, 2005;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our current reports on Form 8-K filed on March&nbsp;11, 2005, April&nbsp;22, 2005, July
8, 2005, as amended by Form 8-K/As filed on July&nbsp;12, 2005 and August&nbsp;1, 2005, July&nbsp;14,
2005, August&nbsp;17, 2005, and August&nbsp;31, 2005; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our Registration Statement on Form 10 filed with the SEC on July 31, 1992, including all amendments or reports filed for the purpose of updating the description of our common stock.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We incorporate by reference additional documents that we will file with the SEC pursuant to
Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act between the date of this prospectus and the
termination date of the Incentive Plan. These documents include periodic reports, such as annual
reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, as well as
proxy statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the extent that any statement in this prospectus is inconsistent with any statement that is
incorporated by reference, the statement in this prospectus shall control. The incorporated
statement shall not be deemed, except as modified or superseded, to constitute a part of this
prospectus or the registration statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may obtain copies of the documents incorporated by reference in this prospectus with
respect to us without charge, excluding any exhibits to those documents unless the exhibit is
specifically incorporated by reference as an exhibit in this prospectus, by requesting them in
writing or by telephone from Brent Turner, Investor Relations, Psychiatric Solutions, Inc., 840
Crescent Centre Drive, Suite&nbsp;460, Franklin, Tennessee 37067; (615)&nbsp;312-5700. You may also obtain
copies of these documents from the SEC through the SEC&#146;s Internet world wide web site or at the
SEC&#146;s address or phone number described in the section captioned &#147;AVAILABLE INFORMATION&#148; above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have filed with the SEC a registration statement on Form S-8 under the Securities Act with
respect to Common Stock offered under this prospectus. This prospectus does not contain all of the
information in the registration statement on Form S-8, parts of which we have omitted, as allowed
under the rules and regulations of the SEC. You should refer to the registration statement
on Form S-8 for further information with respect to us and our Common Stock. Statements
contained
</DIV>

<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in this prospectus as to the contents of any contract or other document are not
necessarily complete and, in each instance, we refer you to the copy of each contract or document
filed as an exhibit to the registration statement on Form S-8. Copies of the registration
statement on Form S-8, including exhibits, may be inspected without charge at the SEC&#146;s principal
office in Washington, D.C. and copied upon payment of the fees prescribed by the SEC.
</DIV>
<DIV align="left">
<A name="106"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>LEGAL MATTERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of shares of our Common Stock offered under this prospectus will be passed upon
on our behalf by Waller Lansden Dortch &#038; Davis, PLLC, Nashville, Tennessee.
</DIV>
<DIV align="left">
<A name="107"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXPERTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of Psychiatric Solutions, Inc. appearing in
Psychiatric Solutions, Inc.&#146;s Annual Report (Form 10-K) for the year ended December&nbsp;31, 2004, and
Psychiatric Solutions, Inc. management&#146;s assessment of the effectiveness of internal control over
financial reporting as of December&nbsp;31, 2004 included therein, have been audited by Ernst &#038; Young
LLP, independent registered public accounting firm, as set forth in their reports thereon included
therein, and incorporated herein by reference. Such financial statements and management&#146;s
assessment are, and audited financial statements and Psychiatric Solutions, Inc. management&#146;s assessments of the effectiveness
of internal control over financial reporting to be included in subsequently filed documents will
be, incorporated herein in reliance upon the reports of Ernst &#038; Young LLP pertaining to such
financial statements and management&#146;s assessments (to the extent covered by consents filed with the
Securities and Exchange Commission) given on the authority of such firm as experts in accounting
and auditing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The combined financial statements of Behavioral Healthcare Services at December&nbsp;31, 2004 and
2003, and for each of the three years in the period ended December&nbsp;31, 2004, appearing in our
Current Reports on Form 8-K/A and Form 8-K, filed with the SEC on August&nbsp;1, 2005 and August 31, 2005, respectively, have been audited by Ernst &#038;
Young LLP, independent auditors, as set forth in their report thereon (which contains an
explanatory paragraph describing conditions that raise substantial doubt about the ability of Behavioral Healthcare Services to continue as a going concern as described in Note 1 to the combined
financial statements), included therein, and incorporated herein by reference. Such combined
financial statements are incorporated herein by reference in reliance upon such report of Ernst &#038;
Young LLP given on the authority of such firm as experts in accounting and auditing.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>NO DEALER, SALESMAN OR ANY OTHER PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE
ANY REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS IN CONNECTION WITH THE OFFERING
HEREIN CONTAINED AND, IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON
AS HAVING BEEN AUTHORIZED BY PSYCHIATRIC SOLUTIONS OR THE SELLING STOCKHOLDERS. THIS PROSPECTUS
DOES NOT CONSTITUTE AN OFFER TO SELL, OR A SOLICITATION OF ANY OFFER TO BUY, THE SECURITIES OFFERED
HEREBY IN ANY JURISDICTION OR TO ANY PERSON WHOM IT IS UNLAWFUL TO MAKE AN OFFER OR SOLICITATION.
NEITHER THE DELIVERY OF THIS PROSPECTUS NOR ANY SALE MADE HEREUNDER SHALL, UNDER ANY CIRCUMSTANCES,
CREATE AN IMPLICATION THAT THERE HAS BEEN NO CHANGE IN THE AFFAIRS OF PSYCHIATRIC SOLUTIONS SINCE
THE DATE HEREOF OR THAT ANY INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO
ITS DATE.</B>
</DIV>


<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXPLANATORY NOTE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This registration statement on Form S-8 relates to the registration of an additional 2,000,000
shares of Common Stock (the &#147;Additional Shares&#148;). The Additional Shares are securities of the
same class as those shares registered in the Registrant&#146;s registration statements on Form S-8,
previously filed with the SEC (Registration Nos. 33-72664, 333-38419, 333-94983, 333-100635 and
333-118529) filed on December&nbsp;8, 1993, October&nbsp;21, 1997, January&nbsp;19, 2000, October&nbsp;18, 2002 and
August&nbsp;25, 2004 respectively, which, pursuant to General Instruction E of Form S-8, are
incorporated by reference herein.
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART II</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
</DIV>


<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;6.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Indemnification of Directors and Officers.</B></TD>
</TR>
</TABLE>
</DIV>




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under Section&nbsp;145 of the Delaware Corporation Law, we are empowered to indemnify our directors
and officers in circumstances therein provided.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Amended and Restated Certificate of Incorporation, as amended, provides that no director
shall be personally liable to us or our stockholders for monetary damages for any breach of
fiduciary duty by such director as a director, except (i)&nbsp;for breach of the director&#146;s duty of
loyalty to us or our stockholders, (ii)&nbsp;for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (iii)&nbsp;pursuant to Section&nbsp;174 of the Delaware
General Corporation Law, or (iv)&nbsp;for any transaction from which the director derived an improper
personal benefit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under our Amended and Restated Bylaws, we must indemnify any person who was or is a party or
is threatened to be made a party to any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative (other than an action by or in
the right of Psychiatric Solutions) by reason of the fact that he or she is or was a director,
officer, employee or agent of Psychiatric Solutions, or is or was serving at our request as a
director, officer, employee or agent of another corporation, partnership, joint venture, trust or
other enterprise, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred by him or her in connection with such action, suit
or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be
in or not opposed to our best interests, and, with respect to any criminal action or proceeding,
had no reasonable cause to believe his or her conduct was unlawful. The termination of any action,
suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or
its equivalent, shall not, of itself, create a presumption that the person did not act in good
faith and in a manner which he or she reasonably believed to be in or not opposed to our best
interests, and, with respect to any criminal action or proceeding, had reasonable cause to believe
that his or her conduct was unlawful.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We must also indemnify any person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action or suit by or in the right of Psychiatric Solutions to
procure a judgment in its favor by reason of the fact that he or she is or was a director, officer,
employee or agent of Psychiatric Solutions, or is or was serving at our request as a director,
officer, employee or agent of another corporation, partnership, joint venture, trust or other
enterprise against expenses (including attorneys&#146; fees) actually and reasonably incurred by him or
her in connection with the defense or settlement of such action or suit if he or she acted in good
faith and in a manner he or she reasonably believed to be in or not opposed to our best interests,
except that no indemnification shall be made in respect of any claim, issue or matter as to which
such person shall
</DIV>

<P align="center" style="font-size: 10pt">II-1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">have been adjudged to be liable for negligence or misconduct in the performance of his or her
duty to us unless and only to the extent that the Court of Chancery or the court in which such
action or suit was brought shall determine upon application that, despite the adjudication of
liability but in view of all the circumstances of the case, such person is fairly and reasonably
entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem
proper.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may purchase and maintain insurance, at our expense, to protect us and any of our
directors, officers, employees or agents or the directors, officers, employees or agents of another
corporation, partnership, joint venture, trust or other enterprise, against any such expense,
liability or loss, to the fullest extent permitted by the Delaware General Corporation Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to separate indemnification agreements we have entered into with each of our
directors, we must indemnify and advance expenses to each director to the fullest extent permitted
by law and as set forth in each agreement and, to the extent applicable, maintain insurance for the
coverage of each director under our policies of directors&#146; and officers&#146; liability insurance.
</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;8.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Exhibits.</B></TD>
</TR>
</TABLE>
</DIV>



<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description of Exhibits</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware
Secretary of State on March&nbsp;9, 1998 (incorporated by reference to Exhibit&nbsp;3.1 to the Company&#146;s
Annual Report on Form&nbsp;10-K for the fiscal year ended April&nbsp;30, 1998).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR
Corporation, filed with the Delaware Secretary of State on August&nbsp;5, 2002 (incorporated by
reference to Exhibit&nbsp;3.2 to the Company&#146;s Quarterly Report on Form&nbsp;10-Q for the quarter ended
July&nbsp;31, 2002).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on March&nbsp;21, 2003 (incorporated by
reference to Appendix&nbsp;A of the Company&#146;s Definitive Proxy Statement, filed on January&nbsp;22,
2003).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Bylaws (incorporated by reference to Exhibit&nbsp;3.2 to the Company&#146;s Annual
Report on Form&nbsp;10-K for the fiscal year ended April&nbsp;30, 1997).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reference is made to Exhibits 3.1 through 3.4.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Common Stock Specimen Certificate (incorporated by reference to Exhibit&nbsp;4.2 to the Company&#146;s
Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2002).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Registration Rights Agreement, dated as of July&nbsp;1, 2005, between Psychiatric Solutions, Inc.
and Ardent Health Services LLC (incorporated by reference to Exhibit&nbsp;4.10 to the Company&#146;s
Registration Statement on Form&nbsp;S-3, filed on August&nbsp;1, 2005 (Registration No.&nbsp;333-127085)).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Waller Lansden Dortch &#038; Davis, PLLC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Ernst &#038; Young LLP.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">II-2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description of Exhibits</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Ernst &#038; Young LLP.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.3*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Waller Lansden Dortch &#038; Davis, PLLC (included in Exhibit&nbsp;5.1).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included on page II-6).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended
(incorporated by reference to Appendix&nbsp;A to the Company&#146;s Definitive Proxy Statement, filed on
April&nbsp;9, 2004, as amended by the Second Amendment to the Psychiatric Solutions, Inc. Equity
Incentive Plan, filed as Appendix&nbsp;A to the Company&#146;s Definitive Proxy Statement on April&nbsp;22,
2005).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><DIV align="left"><DIV style="font-size: 3pt; margin-top: 13pt; width: 18%; border-bottom: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>




<DIV style="margin-top: 3pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Filed herewith</TD>
</TR>

</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">II-3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;9.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Undertakings.</B></TD>
</TR>
</TABLE>
</DIV>




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The undersigned registrant hereby undertakes:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by Section&nbsp;10(a)(3) of the Securities
Act of 1933;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental
change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price represent no more
than a 20&nbsp;percent change in the maximum aggregate offering price set forth in the
&#147;Calculation of Registration Fee&#148; table in the effective registration statement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any material
change of such information in the registration statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Provided, however</I>, that paragraphs 1(i) and 1(ii) do not apply if the information
required to be included in a post-effective amendment by those paragraphs is contained in
periodic reports filed with or furnished to the Commission by the registrant pursuant to
Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated by
reference in the registration statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purposes of determining any liability under the Securities Act of
1933, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The undersigned registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act of 1933, each filing of the registrant&#146;s annual report pursuant
to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
each filing of an employee benefit plan&#146;s annual report pursuant to Section 15(d) of the Securities
Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the registrant pursuant to the
foregoing provisions, or otherwise, the registrant has been informed that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in
the Act and is therefore unenforceable. In the event that a claim for indemnification against such
liabilities (other
</DIV>

<P align="center" style="font-size: 10pt">II-4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">than the payment by the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will be governed by the
final adjudication of such issue.
</DIV>


<P align="center" style="font-size: 10pt">II-5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Franklin, State of Tennessee, on August&nbsp;31, 2005.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">PSYCHIATRIC SOLUTIONS, INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;/s/ Joey A. Jacobs</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Joey A. Jacobs</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Chairman, Chief Executive Officer and
President</I></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>POWER OF ATTORNEY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and
appoints Joey A. Jacobs and Brent Turner, and each of them, his true and lawful attorney-in-fact,
as agent and with full power of substitution and resubstitution for him and in his name, place and
stead, in any and all capacities, to sign any and all amendments to this Registration Statement,
and to file the same, with all exhibits thereto and other documents in connection therewith, with
the Securities and Exchange Commission, granting unto said attorney-in-fact and agents full power
and authority to do and perform each and every act and thing requisite and necessary to be done in
and about the premises, as fully and to all intents and purposes as they might or could do in
person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any
substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the dates indicated.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">SIGNATURE</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">TITLE</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">DATE</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Joey A. Jacobs
<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
Joey A. Jacobs
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chairman, Chief
Executive Officer and
President (Principal
Executive Officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;31, 2005</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Jack E. Polson
<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
Jack E. Polson
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chief Accounting Officer
(Principal Financial and
Accounting Officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;31, 2005</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ William F. Carpenter III
<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
William F. Carpenter III
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;31, 2005</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Mark P. Clein
<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
Mark P. Clein
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;31, 2005</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Richard D. Gore
<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
Richard D. Gore
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;31, 2005</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">SIGNATURE</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">TITLE</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">DATE</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Christopher Grant, Jr.
<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
Christopher Grant, Jr.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;31, 2005</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Ann H. Lamont
<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
Ann H. Lamont
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;31, 2005</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ William M. Petrie, M.D.
<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
William M. Petrie, M.D.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;31, 2005</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Edward K. Wissing
<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
Edward K. Wissing
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;31, 2005</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ David M. Dill
<DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
David M. Dill
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;31, 2005</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX TO EXHIBITS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description of Exhibits</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware
Secretary of State on March&nbsp;9, 1998 (incorporated by reference to Exhibit&nbsp;3.1 to the Company&#146;s
Annual Report on Form&nbsp;10-K for the fiscal year ended April&nbsp;30, 1998).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR
Corporation, filed with the Delaware Secretary of State on August&nbsp;5, 2002 (incorporated by
reference to Exhibit&nbsp;3.2 to the Company&#146;s Quarterly Report on Form&nbsp;10-Q for the quarter ended
July&nbsp;31, 2002).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on March&nbsp;21, 2003 (incorporated by
reference to Appendix&nbsp;A of the Company&#146;s Definitive Proxy Statement, filed on January&nbsp;22,
2003).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Bylaws (incorporated by reference to Exhibit&nbsp;3.2 to the Company&#146;s Annual
Report on Form&nbsp;10-K for the fiscal year ended April&nbsp;30, 1997).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reference is made to Exhibits 3.1 through 3.4.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Common Stock Specimen Certificate (incorporated by reference to Exhibit&nbsp;4.2 to the Company&#146;s
Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2002).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Registration Rights Agreement, dated as of July&nbsp;1, 2005, between Psychiatric Solutions, Inc.
and Ardent Health Services LLC (incorporated by reference to Exhibit&nbsp;4.10 to the Company&#146;s
Registration Statement on Form&nbsp;S-3, filed on August&nbsp;1, 2005 (Registration No.&nbsp;333-127085)).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Waller Lansden Dortch &#038; Davis, PLLC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Ernst &#038; Young LLP.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Ernst &#038; Young LLP.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.3*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Waller Lansden Dortch &#038; Davis, PLLC (included in Exhibit&nbsp;5.1).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included on page II-6).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended
(incorporated by reference to Appendix&nbsp;A to the Company&#146;s Definitive Proxy Statement, filed on
April&nbsp;9, 2004, as amended by the Second Amendment to the Psychiatric Solutions, Inc. Equity
Incentive Plan, filed as Appendix&nbsp;A to the Company&#146;s Definitive Proxy Statement on April&nbsp;22,
2005).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><DIV align="left"><DIV style="font-size: 3pt; margin-top: 13pt; width: 18%; border-bottom: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>




<DIV style="margin-top: 3pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Filed herewith</TD>
</TR>

</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>


</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "g97163sv8.htm", "description": "PSYCHIATRIC SOLUTIONS, INC.", "secsgml_size_bytes": 83253}]
{"company-data": {"conformed-name": "PSYCHIATRIC SOLUTIONS INC", "cik": "0000829608", "assigned-sic": "8093", "irs-number": "232491707", "state-of-incorporation": "DE", "fiscal-year-end": "0430"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-128047", "film-number": "051065093"}, "business-address": {"street1": "113 SEABOARD LANE", "street2": "SUITE C-100", "city": "FRANKLIN", "state": "TN", "zip": "37067", "phone": "615-312-5700"}, "mail-address": {"street1": "113 SEABOARD LANE", "street2": "SUITE C-100", "city": "FRANKLIN", "state": "TN", "zip": "37067"}, "former-company": [{"former-conformed-name": "PMR CORP", "date-changed": "19920703"}, {"former-conformed-name": "ZARON CAPITAL INC", "date-changed": "19891116"}]}
PSYCHIATRIC SOLUTIONS, INC.
Table of Contents
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 1, 2005
REGISTRATION NO. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Form S-8
REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933
PSYCHIATRIC SOLUTIONS, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware
23-2491707
(State or Other Jurisdiction of
Incorporation or Organization)
(I.R.S. Employer
Identification No.)
840 Crescent Centre Drive, Suite 460
Franklin, Tennessee
(Address of Principal Executive Offices)
37067
(Zip Code)
Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan
(Full title of the plan)
Christopher L. Howard, Esq.
Executive Vice President, General Counsel and Secretary
Psychiatric Solutions, Inc.
840 Crescent Centre Drive, Suite 460
Franklin, Tennessee 37067
(Name and Address of Agent for Service)
(615) 312-5700
(Telephone number, including area code, of agent for service)
Copies of all communications to:
James H. Nixon III, Esq.
Waller Lansden Dortch & Davis, PLLC
511 Union Street, Suite 2700
Nashville, Tennessee 37219-1760
(615) 244-6380
CALCULATION OF REGISTRATION FEE
Proposed
Proposed
Amount Of
Title Of Each Class Of Securities To Be
Amount To Be
Maximum Offering Price
Maximum Aggregate
Registration
Registered
Registered (1)
Per Unit
Offering Price
Fee (5)
Common Stock of
Psychiatric
Solutions, Inc.,
par value $0.01 per
share
1,650,151 (2)
$47.00 (4)
$77,557,097
$9,129
Common Stock of
Psychiatric
Solutions, Inc.,
par value $0.01 per
share
349,849 (3)
$44.92
$15,715,218
$1,850
Total
2,000,000
—
$93,272,315
$10,979
(1)
Pursuant to Rule 416 under the Securities Act of 1933, as
amended, this registration statement shall also cover additional
shares of common stock, par value $.01 per share ("Common
Stock"), of Psychiatric Solutions, Inc. ("Psychiatric
Solutions") which become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction.
(2)
Represents shares of Common Stock of
Psychiatric Solutions reserved for issuance pursuant to future
grants of stock options or restricted stock under the Amended and Restated Psychiatric Solutions, Inc. Equity
Incentive Plan, as amended (the "Equity Incentive Plan").
(3)
Represents shares reserved for issuance under the Equity Incentive Plan at a weighted-average
exercise price of $44.92 per share.
(4)
Estimated pursuant to Rule 457(c) solely for purposes of calculating the amount of the
registration fee, based upon the average of the high and low prices of Common Stock of
Psychiatric Solutions, as reported on the Nasdaq National Market on August 26, 2005.
(5)
The Equity Incentive Plan authorizes the issuance of a maximum of 4,933,333 shares of Common
Stock, of which 478,566 shares have been registered pursuant to a previously filed
registration statement on Form S-8 (No. 333-38419), 333,333 shares have been registered on a
previously filed registration statement on Form S-8 (No. 333-94983), 1,623,056 shares have
been registered pursuant to a previously filed registration statement on Form S-8 (No.
333-118529) and 166,666 shares have been registered on a previously filed registration
statement on Form S-8 (No. 33-72664). In connection with the amendment and restatement of the
Equity Incentive Plan on May 6, 2003, the Psychiatric Solutions, Inc. 1997 Incentive and
Non-Qualified Stock Option Plan for Key Personnel (the "Psychiatric Plan") was merged into the
Equity Incentive Plan. The Psychiatric Plan authorized the issuance of a maximum of 331,712
shares of Common Stock, all of which shares have been registered pursuant to a previously
filed registration statement on Form S-8 (No. 333-100635). An additional 2,000,000 shares of
Common Stock are being registered herewith and, in accordance with General Instruction E of
Form S-8, the fee is being paid only with respect to these shares. All share numbers,
purchase prices per share and exercise prices set forth in this registration statement have
been adjusted to reflect the exchange ratio in the merger between Psychiatric Solutions and
PMR Corporation on August 5, 2002 and to reflect a 1-for-3 reverse stock split effected on
August 5, 2002.
Table of Contents
Reoffer Prospectus
2,000,000 Shares
Psychiatric Solutions, Inc.
Common Stock
This prospectus has been prepared for use by certain affiliates and employees (the "Selling
Stockholders") of Psychiatric Solutions, Inc. ("Psychiatric Solutions") who may offer and sell up
to an aggregate of 2,000,000 shares of common stock, par value $.01 per share ("Common Stock"),
that the Selling Stockholders acquire pursuant to the Amended and Restated Psychiatric Solutions,
Inc. Equity Incentive Plan, as amended (the "Incentive Plan"), or upon the exercise, subsequent to
the date of this reoffer prospectus, of stock options granted pursuant to the Incentive Plan.
This prospectus may only be used in conjunction with a supplement, if required under the
Securities Act of 1933, as amended (the "Securities Act"), that contains the names of the Selling
Stockholders and the amount of shares of Common Stock to be reoffered by them except with respect
to sales by non-affiliates of less than the lesser of 1,000 shares or one percent of the shares
issuable under the Incentive Plan.
We will not receive any of the proceeds from the sale of the shares by the Selling
Stockholders. We will bear all expenses (other than underwriting discounts and selling
commissions, fees and expenses of counsel and other advisors to the Selling Stockholders, transfer
taxes and related charges) in connection with the registration of the shares being offered by the
Selling Stockholders.
Our Common Stock is listed on the Nasdaq National Market under the symbol "PSYS." We are
incorporated under the laws of the State of Delaware. Our principal executive offices are located
at 840 Crescent Centre Drive, Suite 460, Franklin, Tennessee 37067 and our telephone number is
(615) 312-5700.
Investing in our Common Stock involves certain risks. Please carefully consider the "Risk
Factors" in our Annual Report on
Form 10-K
filed on March 15, 2005, and incorporated by reference
into this prospectus.
Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission
has approved or disapproved of these securities or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is September 1, 2005.
TABLE OF CONTENTS
Heading
Page
Use of Proceeds
1
Selling Stockholders
1
Plan of Distribution
1
Available Information
1
Incorporation of Certain Information By Reference
2
Legal Matters
3
Experts
3
EX-5.1  OPINION OF WALLER LANSDEN DORTCH & DAVIS, PLLC
EX-23.1  CONSENT OF ERNST & YOUNG LLP
EX-23.2  CONSENT OF ERNST & YOUNG LLP
Table of Contents
USE OF PROCEEDS
We will not receive any proceeds from the sale of shares of Common Stock by the Selling
Stockholders.
SELLING STOCKHOLDERS
The shares of Common Stock issued pursuant to the Incentive Plan or upon the exercise,
subsequent to the date of this reoffer prospectus, of stock options granted pursuant to the
Incentive Plan have been registered under the Securities Act by a registration statement on Form
S-8. This prospectus is to be used in connection with any resales of Common Stock acquired
pursuant to the Incentive Plan after the date of the registration statement on Form S-8 by persons
who may be considered our "affiliates" within the meaning of the Securities Act and other persons
who, although not affiliates, may hold restricted securities previously issued through an employee
benefit plan.
At the date of this prospectus, we do not know the names of persons who intend to resell
shares of Common Stock acquired pursuant to the Incentive Plan. The Selling Stockholders will be
either employees, consultants or advisors of Psychiatric Solutions or its subsidiaries who have
been or may be granted options to purchase Common Stock or restricted shares of Common Stock under
the Incentive Plan. We will supplement this prospectus with the names of the Selling Stockholders
and the amount of shares of Common Stock to be reoffered by them as that information becomes known
and is required by the Securities Act.
PLAN OF DISTRIBUTION
The shares may be offered by the Selling Stockholders from time to time in transactions
through the Nasdaq National Market, in negotiated transactions, through the writing of options on
the shares or a combination of these methods of sale, at prices related to prevailing market prices
or at negotiated prices. The Selling Stockholders may effect these transactions by selling the
shares to or through broker-dealers and these broker-dealers may receive compensation in the form
of discounts, concessions or commissions from the Selling Stockholders and/or the purchaser of the
shares for which such broker-dealers may act as agent or to whom they sell as principal, or both.
This compensation as to a particular broker-dealer may be in excess of customary commissions.
There is no assurance that any of the Selling Stockholders will sell any or all of the shares
of Common Stock offered under this prospectus.
AVAILABLE INFORMATION
We are subject to the informational requirements of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), and, in accordance therewith, we file reports, proxy statements and
other information with the SEC under the Exchange Act. You may read and copy this information on
our website at www.psysolutions.com and at the following locations of the SEC:
Public Reference Room
New York Regional Office
Chicago Regional Office
450 Fifth Street, N.W.
Woolworth Center
Citicorp Center, Suite 1400
Room 1024
233 Broadway
500 West Madison Street
Washington, D.C. 20549
New York, NY 10279
Chicago, IL 60661-2511
You may also obtain copies of this information by mail from the Public Reference Section of
the SEC, 450 Fifth Street, N.W., Room 1024, Washington, D.C. 20549, at prescribed rates. You may
obtain information on the operation of the Public Reference Room by calling the SEC at
1-800-SEC-0330. The SEC also maintains an Internet world wide web site that contains reports, proxy
1
Table of Contents
statements and other information about issuers, like us, that file electronically with the
SEC. The address of that site is http://www.sec.gov. You may also inspect reports, proxy statements
and other information about us at the offices of the Nasdaq Stock Market, 9600 Blackwell Road,
Rockville, Maryland 20850.
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
The SEC allows us to "incorporate by reference" information into this prospectus from
documents that we have previously filed with the SEC. This means that we can disclose important
information to you by referring you to another document filed separately with the SEC. These
documents contain important information about us and our financial condition. The information
incorporated by reference is considered to be a part of this prospectus, except for any information
that is superseded by other information that is set forth directly in this document.
This prospectus incorporates by reference the following documents with respect to us (file
number: 0-20488):
1.
Our annual report on Form 10-K for the year ended December 31, 2004;
2.
Our quarterly reports on Form 10-Q for the quarters ended March 31, 2005 and
June 30, 2005;
3.
Our current reports on Form 8-K filed on March 11, 2005, April 22, 2005, July
8, 2005, as amended by Form 8-K/As filed on July 12, 2005 and August 1, 2005, July 14,
2005, August 17, 2005, and August 31, 2005; and
4.
Our Registration Statement on Form 10 filed with the SEC on July 31, 1992, including all amendments or reports filed for the purpose of updating the description of our common stock.
We incorporate by reference additional documents that we will file with the SEC pursuant to
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act between the date of this prospectus and the
termination date of the Incentive Plan. These documents include periodic reports, such as annual
reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, as well as
proxy statements.
To the extent that any statement in this prospectus is inconsistent with any statement that is
incorporated by reference, the statement in this prospectus shall control. The incorporated
statement shall not be deemed, except as modified or superseded, to constitute a part of this
prospectus or the registration statement.
You may obtain copies of the documents incorporated by reference in this prospectus with
respect to us without charge, excluding any exhibits to those documents unless the exhibit is
specifically incorporated by reference as an exhibit in this prospectus, by requesting them in
writing or by telephone from Brent Turner, Investor Relations, Psychiatric Solutions, Inc., 840
Crescent Centre Drive, Suite 460, Franklin, Tennessee 37067; (615) 312-5700. You may also obtain
copies of these documents from the SEC through the SEC's Internet world wide web site or at the
SEC's address or phone number described in the section captioned "AVAILABLE INFORMATION" above.
We have filed with the SEC a registration statement on Form S-8 under the Securities Act with
respect to Common Stock offered under this prospectus. This prospectus does not contain all of the
information in the registration statement on Form S-8, parts of which we have omitted, as allowed
under the rules and regulations of the SEC. You should refer to the registration statement
on Form S-8 for further information with respect to us and our Common Stock. Statements
contained
2
Table of Contents
in this prospectus as to the contents of any contract or other document are not
necessarily complete and, in each instance, we refer you to the copy of each contract or document
filed as an exhibit to the registration statement on Form S-8. Copies of the registration
statement on Form S-8, including exhibits, may be inspected without charge at the SEC's principal
office in Washington, D.C. and copied upon payment of the fees prescribed by the SEC.
LEGAL MATTERS
The validity of shares of our Common Stock offered under this prospectus will be passed upon
on our behalf by Waller Lansden Dortch & Davis, PLLC, Nashville, Tennessee.
EXPERTS
The consolidated financial statements of Psychiatric Solutions, Inc. appearing in
Psychiatric Solutions, Inc.'s Annual Report (Form 10-K) for the year ended December 31, 2004, and
Psychiatric Solutions, Inc. management's assessment of the effectiveness of internal control over
financial reporting as of December 31, 2004 included therein, have been audited by Ernst & Young
LLP, independent registered public accounting firm, as set forth in their reports thereon included
therein, and incorporated herein by reference. Such financial statements and management's
assessment are, and audited financial statements and Psychiatric Solutions, Inc. management's assessments of the effectiveness
of internal control over financial reporting to be included in subsequently filed documents will
be, incorporated herein in reliance upon the reports of Ernst & Young LLP pertaining to such
financial statements and management's assessments (to the extent covered by consents filed with the
Securities and Exchange Commission) given on the authority of such firm as experts in accounting
and auditing.
The combined financial statements of Behavioral Healthcare Services at December 31, 2004 and
2003, and for each of the three years in the period ended December 31, 2004, appearing in our
Current Reports on Form 8-K/A and Form 8-K, filed with the SEC on August 1, 2005 and August 31, 2005, respectively, have been audited by Ernst &
Young LLP, independent auditors, as set forth in their report thereon (which contains an
explanatory paragraph describing conditions that raise substantial doubt about the ability of Behavioral Healthcare Services to continue as a going concern as described in Note 1 to the combined
financial statements), included therein, and incorporated herein by reference. Such combined
financial statements are incorporated herein by reference in reliance upon such report of Ernst &
Young LLP given on the authority of such firm as experts in accounting and auditing.
NO DEALER, SALESMAN OR ANY OTHER PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE
ANY REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS IN CONNECTION WITH THE OFFERING
HEREIN CONTAINED AND, IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON
AS HAVING BEEN AUTHORIZED BY PSYCHIATRIC SOLUTIONS OR THE SELLING STOCKHOLDERS. THIS PROSPECTUS
DOES NOT CONSTITUTE AN OFFER TO SELL, OR A SOLICITATION OF ANY OFFER TO BUY, THE SECURITIES OFFERED
HEREBY IN ANY JURISDICTION OR TO ANY PERSON WHOM IT IS UNLAWFUL TO MAKE AN OFFER OR SOLICITATION.
NEITHER THE DELIVERY OF THIS PROSPECTUS NOR ANY SALE MADE HEREUNDER SHALL, UNDER ANY CIRCUMSTANCES,
CREATE AN IMPLICATION THAT THERE HAS BEEN NO CHANGE IN THE AFFAIRS OF PSYCHIATRIC SOLUTIONS SINCE
THE DATE HEREOF OR THAT ANY INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO
ITS DATE.
3
Table of Contents
EXPLANATORY NOTE
This registration statement on Form S-8 relates to the registration of an additional 2,000,000
shares of Common Stock (the "Additional Shares"). The Additional Shares are securities of the
same class as those shares registered in the Registrant's registration statements on Form S-8,
previously filed with the SEC (Registration Nos. 33-72664, 333-38419, 333-94983, 333-100635 and
333-118529) filed on December 8, 1993, October 21, 1997, January 19, 2000, October 18, 2002 and
August 25, 2004 respectively, which, pursuant to General Instruction E of Form S-8, are
incorporated by reference herein.
Table of Contents
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 6.
Indemnification of Directors and Officers.
Under Section 145 of the Delaware Corporation Law, we are empowered to indemnify our directors
and officers in circumstances therein provided.
Our Amended and Restated Certificate of Incorporation, as amended, provides that no director
shall be personally liable to us or our stockholders for monetary damages for any breach of
fiduciary duty by such director as a director, except (i) for breach of the director's duty of
loyalty to us or our stockholders, (ii) for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (iii) pursuant to Section 174 of the Delaware
General Corporation Law, or (iv) for any transaction from which the director derived an improper
personal benefit.
Under our Amended and Restated Bylaws, we must indemnify any person who was or is a party or
is threatened to be made a party to any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative (other than an action by or in
the right of Psychiatric Solutions) by reason of the fact that he or she is or was a director,
officer, employee or agent of Psychiatric Solutions, or is or was serving at our request as a
director, officer, employee or agent of another corporation, partnership, joint venture, trust or
other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred by him or her in connection with such action, suit
or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be
in or not opposed to our best interests, and, with respect to any criminal action or proceeding,
had no reasonable cause to believe his or her conduct was unlawful. The termination of any action,
suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or
its equivalent, shall not, of itself, create a presumption that the person did not act in good
faith and in a manner which he or she reasonably believed to be in or not opposed to our best
interests, and, with respect to any criminal action or proceeding, had reasonable cause to believe
that his or her conduct was unlawful.
We must also indemnify any person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action or suit by or in the right of Psychiatric Solutions to
procure a judgment in its favor by reason of the fact that he or she is or was a director, officer,
employee or agent of Psychiatric Solutions, or is or was serving at our request as a director,
officer, employee or agent of another corporation, partnership, joint venture, trust or other
enterprise against expenses (including attorneys' fees) actually and reasonably incurred by him or
her in connection with the defense or settlement of such action or suit if he or she acted in good
faith and in a manner he or she reasonably believed to be in or not opposed to our best interests,
except that no indemnification shall be made in respect of any claim, issue or matter as to which
such person shall
II-1
Table of Contents
have been adjudged to be liable for negligence or misconduct in the performance of his or her
duty to us unless and only to the extent that the Court of Chancery or the court in which such
action or suit was brought shall determine upon application that, despite the adjudication of
liability but in view of all the circumstances of the case, such person is fairly and reasonably
entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem
proper.
We may purchase and maintain insurance, at our expense, to protect us and any of our
directors, officers, employees or agents or the directors, officers, employees or agents of another
corporation, partnership, joint venture, trust or other enterprise, against any such expense,
liability or loss, to the fullest extent permitted by the Delaware General Corporation Law.
Pursuant to separate indemnification agreements we have entered into with each of our
directors, we must indemnify and advance expenses to each director to the fullest extent permitted
by law and as set forth in each agreement and, to the extent applicable, maintain insurance for the
coverage of each director under our policies of directors' and officers' liability insurance.
Item 8.
Exhibits.
Exhibit
Number
Description of Exhibits
3.1
Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware
Secretary of State on March 9, 1998 (incorporated by reference to Exhibit 3.1 to the Company's
Annual Report on Form 10-K for the fiscal year ended April 30, 1998).
3.2
Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR
Corporation, filed with the Delaware Secretary of State on August 5, 2002 (incorporated by
reference to Exhibit 3.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended
July 31, 2002).
3.3
Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on March 21, 2003 (incorporated by
reference to Appendix A of the Company's Definitive Proxy Statement, filed on January 22,
2003).
3.4
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company's Annual
Report on Form 10-K for the fiscal year ended April 30, 1997).
4.1
Reference is made to Exhibits 3.1 through 3.4.
4.2
Common Stock Specimen Certificate (incorporated by reference to Exhibit 4.2 to the Company's
Annual Report on Form 10-K for the fiscal year ended December 31, 2002).
4.3
Registration Rights Agreement, dated as of July 1, 2005, between Psychiatric Solutions, Inc.
and Ardent Health Services LLC (incorporated by reference to Exhibit 4.10 to the Company's
Registration Statement on Form S-3, filed on August 1, 2005 (Registration No. 333-127085)).
5.1*
Opinion of Waller Lansden Dortch & Davis, PLLC.
23.1*
Consent of Ernst & Young LLP.
II-2
Table of Contents
Exhibit
Number
Description of Exhibits
23.2*
Consent of Ernst & Young LLP.
23.3*
Consent of Waller Lansden Dortch & Davis, PLLC (included in Exhibit 5.1).
24.1*
Power of Attorney (included on page II-6).
99.1
Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended
(incorporated by reference to Appendix A to the Company's Definitive Proxy Statement, filed on
April 9, 2004, as amended by the Second Amendment to the Psychiatric Solutions, Inc. Equity
Incentive Plan, filed as Appendix A to the Company's Definitive Proxy Statement on April 22,
2005).
*
Filed herewith
II-3
Table of Contents
Item 9.
Undertakings.
(a) The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
(i) To include any prospectus required by Section 10(a)(3) of the Securities
Act of 1933;
(ii) To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental
change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price represent no more
than a 20 percent change in the maximum aggregate offering price set forth in the
"Calculation of Registration Fee" table in the effective registration statement;
(iii) To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any material
change of such information in the registration statement.
Provided, however
, that paragraphs 1(i) and 1(ii) do not apply if the information
required to be included in a post-effective amendment by those paragraphs is contained in
periodic reports filed with or furnished to the Commission by the registrant pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated by
reference in the registration statement.
(2) That, for the purposes of determining any liability under the Securities Act of
1933, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the offering.
(b) The undersigned registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant
to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities
Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the registrant pursuant to the
foregoing provisions, or otherwise, the registrant has been informed that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in
the Act and is therefore unenforceable. In the event that a claim for indemnification against such
liabilities (other
II-4
Table of Contents
than the payment by the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will be governed by the
final adjudication of such issue.
II-5
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Franklin, State of Tennessee, on August 31, 2005.
PSYCHIATRIC SOLUTIONS, INC.
By:
/s/ Joey A. Jacobs
Joey A. Jacobs
Chairman, Chief Executive Officer and
President
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and
appoints Joey A. Jacobs and Brent Turner, and each of them, his true and lawful attorney-in-fact,
as agent and with full power of substitution and resubstitution for him and in his name, place and
stead, in any and all capacities, to sign any and all amendments to this Registration Statement,
and to file the same, with all exhibits thereto and other documents in connection therewith, with
the Securities and Exchange Commission, granting unto said attorney-in-fact and agents full power
and authority to do and perform each and every act and thing requisite and necessary to be done in
and about the premises, as fully and to all intents and purposes as they might or could do in
person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any
substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE
TITLE
DATE
/s/ Joey A. Jacobs
Joey A. Jacobs
Chairman, Chief
Executive Officer and
President (Principal
Executive Officer)
August 31, 2005
/s/ Jack E. Polson
Jack E. Polson
Chief Accounting Officer
(Principal Financial and
Accounting Officer)
August 31, 2005
/s/ William F. Carpenter III
William F. Carpenter III
Director
August 31, 2005
/s/ Mark P. Clein
Mark P. Clein
Director
August 31, 2005
/s/ Richard D. Gore
Richard D. Gore
Director
August 31, 2005
Table of Contents
SIGNATURE
TITLE
DATE
/s/ Christopher Grant, Jr.
Christopher Grant, Jr.
Director
August 31, 2005
/s/ Ann H. Lamont
Ann H. Lamont
Director
August 31, 2005
/s/ William M. Petrie, M.D.
William M. Petrie, M.D.
Director
August 31, 2005
/s/ Edward K. Wissing
Edward K. Wissing
Director
August 31, 2005
/s/ David M. Dill
David M. Dill
Director
August 31, 2005
Table of Contents
INDEX TO EXHIBITS
Exhibit
Number
Description of Exhibits
3.1
Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware
Secretary of State on March 9, 1998 (incorporated by reference to Exhibit 3.1 to the Company's
Annual Report on Form 10-K for the fiscal year ended April 30, 1998).
3.2
Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR
Corporation, filed with the Delaware Secretary of State on August 5, 2002 (incorporated by
reference to Exhibit 3.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended
July 31, 2002).
3.3
Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric
Solutions, Inc., filed with the Delaware Secretary of State on March 21, 2003 (incorporated by
reference to Appendix A of the Company's Definitive Proxy Statement, filed on January 22,
2003).
3.4
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company's Annual
Report on Form 10-K for the fiscal year ended April 30, 1997).
4.1
Reference is made to Exhibits 3.1 through 3.4.
4.2
Common Stock Specimen Certificate (incorporated by reference to Exhibit 4.2 to the Company's
Annual Report on Form 10-K for the fiscal year ended December 31, 2002).
4.3
Registration Rights Agreement, dated as of July 1, 2005, between Psychiatric Solutions, Inc.
and Ardent Health Services LLC (incorporated by reference to Exhibit 4.10 to the Company's
Registration Statement on Form S-3, filed on August 1, 2005 (Registration No. 333-127085)).
5.1*
Opinion of Waller Lansden Dortch & Davis, PLLC.
23.1*
Consent of Ernst & Young LLP.
23.2*
Consent of Ernst & Young LLP.
23.3*
Consent of Waller Lansden Dortch & Davis, PLLC (included in Exhibit 5.1).
24.1*
Power of Attorney (included on page II-6).
99.1
Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended
(incorporated by reference to Appendix A to the Company's Definitive Proxy Statement, filed on
April 9, 2004, as amended by the Second Amendment to the Psychiatric Solutions, Inc. Equity
Incentive Plan, filed as Appendix A to the Company's Definitive Proxy Statement on April 22,
2005).
*
Filed herewith